Literature DB >> 15768016

Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha.

Alan Dardik1, Akimasa Yamashita, Faisal Aziz, Hidenori Asada, Bauer E Sumpio.   

Abstract

OBJECTIVE: Vascular smooth muscle cell (SMC) migration is critical to the development of atherosclerosis and neointimal hyperplasia. Hemodynamic forces such as shear stress and cyclic strain stimulate endothelial cell signal-transduction pathways, resulting in the secretion of several factors, including SMC chemoattractants such as platelet-derived growth factor (PDGF). We hypothesized that mechanical forces stimulate endothelial cells to secrete SMC chemoattractants to induce migration via the mitogen-activated protein kinase (MAPK) pathway.
METHODS: Bovine aortic endothelial cells were exposed to shear stress, cyclic strain, or static conditions for 16 hours. The resulting conditioned medium was used as a SMC chemoattractant in a Boyden chamber. Activation of SMC extracellular signal-regulated protein kinase 1/2 (ERK1/2) was assessed by Western blot analysis. Pathways were inhibited with anti-PDGF-BB or anti-interleukin-1alpha (IL-1alpha) antibodies, or the ERK1/2 upstream pathway inhibitor PD98059.
RESULTS: Conditioned medium from endothelial cells exposed to shear stress corresponding to arterial levels of shear stress stimulated SMC migration but lower levels of shear stress or cyclic strain did not. Both PDGF-BB and IL-1alpha were secreted into the conditioned medium by endothelial cells stimulated with shear stress. Both PDGF-BB and IL-1alpha stimulated SMC chemotaxis but were not synergistic, and both stimulated SMC ERK1/2 phosphorylation. Inhibition of PDGF-BB or IL-1alpha inhibited SMC chemotaxis and ERK1/2 phosphorylation.
CONCLUSION: Shear stress stimulates endothelial cells to secrete several SMC chemoattractants, including PDGF-BB and IL-1alpha; both PDGF-BB and IL-1alpha stimulate SMC chemotaxis via the ERK1/2 signal-transduction pathway. These results suggest that the response to vascular injury may have a common pathway amenable to pharmacologic manipulation. CLINICAL RELEVANCE: One difficulty in the pharmacologic treatment of atherosclerosis or neointimal hyperplasia leading to restenosis is the multiplicity of activated pathways and thus potential treatment targets. This study demonstrates that shear stress, a hemodynamic force that may be a biologically relevant stimulus to induce vascular pathology, stimulates endothelial cells to secrete PDGF-BB and IL-1alpha. Both of these mediators stimulate the SMC ERK1/2 pathway to induce migration, a critical event in the pathogenesis of atherosclerosis and neointimal hyperplasia. Therefore, this study suggests a relevant common target pathway in SMC that is amenable to manipulation for clinical treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15768016     DOI: 10.1016/j.jvs.2004.11.016

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  34 in total

1.  Fluid-Structure Interactions of the Mitral Valve and Left Heart: Comprehensive Strategies, Past, Present and Future.

Authors:  Daniel R Einstein; Facundo Del Pin; Xiangmin Jiao; Andrew P Kuprat; James P Carson; Karyn S Kunzelman; Richard P Cochran; Julius M Guccione; Mark B Ratcliffe
Journal:  Int J Numer Methods Eng       Date:  2010-03       Impact factor: 3.477

Review 2.  Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons.

Authors:  Akihito Muto; Tamara N Fitzgerald; Jose M Pimiento; Stephen P Maloney; Desarom Teso; Jacek J Paszkowiak; Tormod S Westvik; Fabio A Kudo; Toshiya Nishibe; Alan Dardik
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

Review 3.  Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding.

Authors:  Juhui Qiu; Yiming Zheng; Jianjun Hu; Donghua Liao; Hans Gregersen; Xiaoyan Deng; Yubo Fan; Guixue Wang
Journal:  J R Soc Interface       Date:  2013-10-23       Impact factor: 4.118

Review 4.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

5.  Vibration enhanced cell growth induced by surface acoustic waves as in vitro wound-healing model.

Authors:  Manuel S Brugger; Kathrin Baumgartner; Sophie C F Mauritz; Stefan C Gerlach; Florian Röder; Christine Schlosser; Regina Fluhrer; Achim Wixforth; Christoph Westerhausen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-30       Impact factor: 11.205

Review 6.  Endothelial shear stress and blood viscosity in peripheral arterial disease.

Authors:  Young I Cho; Daniel J Cho; Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

Review 7.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

8.  TGFβ (Transforming Growth Factor-Beta)-Activated Kinase 1 Regulates Arteriovenous Fistula Maturation.

Authors:  Haidi Hu; Shin-Rong Lee; Hualong Bai; Jianming Guo; Takuya Hashimoto; Toshihiko Isaji; Xiangjiang Guo; Tun Wang; Katharine Wolf; Shirley Liu; Shun Ono; Bogdan Yatsula; Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-28       Impact factor: 8.311

9.  Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A.

Authors:  M Campbell; P Anderson; E R Trimble
Journal:  Diabetologia       Date:  2008-03-14       Impact factor: 10.122

10.  Olibanum extract inhibits vascular smooth muscle cell migration and proliferation in response to platelet-derived growth factor.

Authors:  Ok-Byung Choi; Joo-Hoon Park; Ye Jin Lee; Chang-Kwon Lee; Kyung-Jong Won; Junghwan Kim; Hwan Myung Lee; Bokyung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.